Brief: Neubase Announces Positive Preclinical Data Supporting The Capabilities Of Stealth Editors
22/05/2023 12:43
May 22 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE ANNOUNCES POSITIVE PRECLINICAL DATA SUPPORTING THE
CAPABILITIES OF STEALTH EDITORS™
Source text for Eikon: ID:nGNX1YSMG7
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet